{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Corona",
      "state": "CA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "63246",
      "recalling_firm": "Watson Laboratories Inc",
      "address_1": "311 Bonnie Cir",
      "address_2": "N/A",
      "postal_code": "92880-2882",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-058-2013",
      "product_description": "Hydrocodone Bitartrate and Acetaminophen Tablets USP, 10 mg/500 mg, 500-count Tablets per bottle, Rx only, Manufactured By: Watson Laboratories, Inc., Corona, CA  92880 USA, NDC 00591-0540-05.",
      "product_quantity": "4,874 bottles",
      "reason_for_recall": "Superpotent (Multiple Ingredient) Drug: There is the potential for oversized and superpotent tablets.",
      "recall_initiation_date": "20120921",
      "center_classification_date": "20121116",
      "termination_date": "20140324",
      "report_date": "20121128",
      "code_info": "Lot #: 519406A, 521759A, Exp 04/14"
    }
  ]
}